Senior insider sale
Chief Medical Officer at VERICEL CORP — senior position signals high conviction
$906.6K
20K shares
What this filing means
HOPPER JONATHAN MARK plans to sell 20K shares of VERICEL CORP valued at approximately $906.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/2/2025ACC: 0001959173-25-003666
Officer· Chief Medical Officer
Since Feb 2020
20K
Shares to sell
$906.6K
Approx. market value
10K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Options Granted - 02/11/2020
Cash
6/2/2025
10KTotal acquired10K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/2/2025 | Options Granted - 02/11/2020 Cash | 10K | — |
| Total | 10K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
10K
Market value
$495.3K
3/3/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
10K
Market value
$411.3K
6/2/2025
Total
Units
20K
Value
$906.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/3/2025 | 10K | $495.3K | — | Completed |
| Planned — Approximate Date | ||||
6/2/2025 | 10K | $411.3K | NASDAQ | Planned |
| Total | 20K | $906.6K | ||